227
Views
14
CrossRef citations to date
0
Altmetric
Case Reports

Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report

, , , , , , , , & show all
Pages 1150-1153 | Received 05 Feb 2017, Accepted 28 May 2017, Published online: 12 Jun 2017

References

  • Malek N, Stewart W, Greene J. The progressive myoclonic epilepsies. Pract Neurol 2015 Jun;15(3):164–71.
  • Turnbull J, Tiberia E, Striano P, et al. Lafora disease. Epileptic Disord 2016 Sep 1;18(S2):38–62.
  • Striano P, Zara F, Turnbull J, et al. Typical progression of myoclonic epilepsy of the Lafora type. Nat Clin Pract Neurol 2008;4:106–11.
  • Gomez-Abad C, Gomez-Garre P, Gutierrez-Delicado E, et al. Lafora disease due to EP2B mutations: a clinical and genetic study. Neurology 2005;64(6):982–6.
  • Lesca G, Boutry-Kryza N, de Toffol B, et al. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease. Epilepsia 2010 Sep;51(9):1691–8.
  • Franceschetti S, Gambardella A, Canafoglia L, et al. Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia 2006 Mar;47(3):640–3.
  • Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012;79(11):1094–100.
  • The Lafora Progressive Myoclonus Epilepsy Mutation and Polymorphism Database - Toronto database - the Centre for Applied Genomics: http://projects.tcag.ca/lafora/
  • Couarch P, Vernia S, Gourfinkel-An I, et al. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism. J Mol Med (Berl) 2011 Sep;89(9):915–25.
  • Salar S, Yeni N, Gündüz A, et al. Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families. Epilepsy Res 2012 Feb;98(2–3):273–6.
  • Traoré M, Landouré G, Motley W, et al. Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease. Neurogenetics 2009 Oct;10(4):319–23.
  • Chan EM, Bulman DE, Paterson AD, et al. Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J Med Genet 2003 Sep;40(9):671–5.
  • Lanoiselée H-M, Genton P, Lesca G, et al. Are c.436G>A mutations less severe forms of Lafora disease? A case report. Epilepsy Behav Case Rep 2014;2:19–21.
  • Singh S, Sethi I, Francheschetti S, et al. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy. J Med Genet 2006 Sep;43(9):e48.
  • Ganesh S, Puri R, Singh S, et al. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy. J Hum Genet 2006;51(1):1–8. Epub 2005 Nov 26.
  • Brackmann FA, Kiefer A, Agaimy A, et al. Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation. Pediatr Neurol 2011 Jun;44(6):475–7.
  • Kecmanović M, Jović N, Cukić M, et al. Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene. J Neurol Sci 2013 Feb 15;325(1–2):170–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.